April 27, 2026

DNS Africa Resource Center

..sharing knowledge.

A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant … – Nature.com

A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant …  Nature.com
source

About The Author